Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Neelapu
Immune Evasion of Mantle Cell Lymphoma: Expression of B7-H1 Leads to Inhibited T-Cell Response to and Killing of Tumor Cells
Haematologica
Hematology
Very Early FDG Pet/Ct Scan May Predict Outcomes in Relapsed or Refractory DLBCL Patients Treated With Salvage Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Lenalidomide and Obinutuzumab With Chop for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I/Ii Results
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Combination of Ibrutinib With Rituximab (Ir) Is Highly Effective in Previously Untreated Elderly (>65 Years) Patients (Pts) With Mantle Cell Lymphoma (Mcl) - Phase Ii Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Immunologic Doublet of Lenalidomide Plus Obinutuzumab Is Highly Active in Relapsed/Refractory Follicular Lymphoma, Results of a Phase I/Ii Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone Prior to Combination With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Rituximab, Lenalidomide, and Ibrutinib Alone and Combined With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
